Yvonne S.L. Mak

Discovery of a Potent and Specific <i>M. tuberculosis</i> Leucyl-tRNA Synthetase Inhibitor: (<i>S</i>)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol (GSK656)

Xianfeng Li, Vincent Hernandez, Fernando Rock et al. · Journal of Medicinal Chemistry · 2017 · 162 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes

Dong Chen, Charlotte Virtucio, Olga Zemska et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 88 citations

Medicine, Dermatology, Pharmacology +15

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

Siler H. Panowski, Surabhi Srinivasan, Nguyêñ Duy Tân et al. · Cancer Research · 2022 · 88 citations

Medicine, Immunology, Oncology +17

Direct control of CAR T cells through small molecule-regulated antibodies

Spencer Park, Edward Pascua, Kevin C. Lindquist et al. · Nature Communications · 2021 · 50 citations · Full text

Pharmacy, Immunology, Medicinal Chemistry +17

Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer

Yi Zhang, Silvia K. Tacheva-Grigorova, Janette Sutton et al. · Clinical Cancer Research · 2023 · 48 citations

Medicine, Immunology, Oncology +17